Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death

To identify therapeutic opportunities for oncolytic viral therapy, we conducted genome-wide RNAi screens to search for host factors that modulate rhabdoviral oncolysis. Our screens uncovered the endoplasmic reticulum (ER) stress response pathways as important modulators of rhabdovirus-mediated cytot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer cell 2011-10, Vol.20 (4), p.443-456
Hauptverfasser: Mahoney, Douglas J., Lefebvre, Charles, Allan, Kristina, Brun, Jan, Sanaei, Cina A., Baird, Stephen, Pearce, Nelson, Grönberg, Susanna, Wilson, Brian, Prakesh, Mikael, Aman, Ahmed, Isaac, Methvin, Mamai, Ahmed, Uehling, David, Al-Awar, Rima, Falls, Theresa, Alain, Tommy, Stojdl, David F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 456
container_issue 4
container_start_page 443
container_title Cancer cell
container_volume 20
creator Mahoney, Douglas J.
Lefebvre, Charles
Allan, Kristina
Brun, Jan
Sanaei, Cina A.
Baird, Stephen
Pearce, Nelson
Grönberg, Susanna
Wilson, Brian
Prakesh, Mikael
Aman, Ahmed
Isaac, Methvin
Mamai, Ahmed
Uehling, David
Al-Awar, Rima
Falls, Theresa
Alain, Tommy
Stojdl, David F.
description To identify therapeutic opportunities for oncolytic viral therapy, we conducted genome-wide RNAi screens to search for host factors that modulate rhabdoviral oncolysis. Our screens uncovered the endoplasmic reticulum (ER) stress response pathways as important modulators of rhabdovirus-mediated cytotoxicity. Further investigation revealed an unconventional mechanism whereby ER stress response inhibition preconditioned cancer cells, which sensitized them to caspase-2-dependent apoptosis induced by a subsequent rhabdovirus infection. Importantly, this mechanism was tumor cell specific, selectively increasing potency of the oncolytic virus by up to 10,000-fold. In vivo studies using a small molecule inhibitor of IRE1α showed dramatically improved oncolytic efficacy in resistant tumor models. Our study demonstrates proof of concept for using functional genomics to improve biotherapeutic agents for cancer. ► RNAi screen finds UPR/ERAD blockade sensitizes cancer cells to oncolytic therapy ► Cellular response to ER stress, not acute stress, predisposes cancer cells to death ► PIDD-independent caspase-2 mechanism is triggered by virus infection ► Chemical inhibition of IRE1α improves oncolytic virus therapy in vivo
doi_str_mv 10.1016/j.ccr.2011.09.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_920799091</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1535610811003539</els_id><sourcerecordid>920799091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-aabb142854804cdf02f83fa38aa5bb3540b7f20194011171e798df4f9c611c423</originalsourceid><addsrcrecordid>eNqFUcFu1DAUtBCIlsIHcEG-cUp4TpzEFie0LVCpUqW2cLUc53nxapMstlOp_8BH86JdOMLJ1nhm3vMMY28FlAJE-2FXOhfLCoQoQZcAzTN2LlSnirpV7XO6N3VTtALUGXuV0g5IIzr9kp1VpJFNJ87Zr-8hLql4WMY58uspY7QuzyPyexcRJ36Hj2j3iV_d8fscMSVC0mGeEvKNXZ8Pcd5GO65wSNlOecUdxsQ9Od5Obt4_5eD4aU4M2y1GHIiVDjZhUfEN7vf8Em3-8Zq98DQM35zOC_bt89XD5mtxc_vlevPppnBS17mwtu-FrFQjFUg3eKi8qr2tlbVN39eNhL7z9EMtKRnRCey0Grz02rVCOFnVF-z90ZeW_7lgymYMydEadsJ5SUZX0GkNWvyfCdDW0HYNMcWR6eKcUkRvDjGMNj4ZAWZty-wMtWXWtgxoQ22R5t3JfelHHP4q_tRDhI9HAlIajwGjSS4gxTuEiC6bYQ7_sP8Nm1ilgg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>900630675</pqid></control><display><type>article</type><title>Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Cell Press Free Archives</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mahoney, Douglas J. ; Lefebvre, Charles ; Allan, Kristina ; Brun, Jan ; Sanaei, Cina A. ; Baird, Stephen ; Pearce, Nelson ; Grönberg, Susanna ; Wilson, Brian ; Prakesh, Mikael ; Aman, Ahmed ; Isaac, Methvin ; Mamai, Ahmed ; Uehling, David ; Al-Awar, Rima ; Falls, Theresa ; Alain, Tommy ; Stojdl, David F.</creator><creatorcontrib>Mahoney, Douglas J. ; Lefebvre, Charles ; Allan, Kristina ; Brun, Jan ; Sanaei, Cina A. ; Baird, Stephen ; Pearce, Nelson ; Grönberg, Susanna ; Wilson, Brian ; Prakesh, Mikael ; Aman, Ahmed ; Isaac, Methvin ; Mamai, Ahmed ; Uehling, David ; Al-Awar, Rima ; Falls, Theresa ; Alain, Tommy ; Stojdl, David F.</creatorcontrib><description>To identify therapeutic opportunities for oncolytic viral therapy, we conducted genome-wide RNAi screens to search for host factors that modulate rhabdoviral oncolysis. Our screens uncovered the endoplasmic reticulum (ER) stress response pathways as important modulators of rhabdovirus-mediated cytotoxicity. Further investigation revealed an unconventional mechanism whereby ER stress response inhibition preconditioned cancer cells, which sensitized them to caspase-2-dependent apoptosis induced by a subsequent rhabdovirus infection. Importantly, this mechanism was tumor cell specific, selectively increasing potency of the oncolytic virus by up to 10,000-fold. In vivo studies using a small molecule inhibitor of IRE1α showed dramatically improved oncolytic efficacy in resistant tumor models. Our study demonstrates proof of concept for using functional genomics to improve biotherapeutic agents for cancer. ► RNAi screen finds UPR/ERAD blockade sensitizes cancer cells to oncolytic therapy ► Cellular response to ER stress, not acute stress, predisposes cancer cells to death ► PIDD-independent caspase-2 mechanism is triggered by virus infection ► Chemical inhibition of IRE1α improves oncolytic virus therapy in vivo</description><identifier>ISSN: 1535-6108</identifier><identifier>EISSN: 1878-3686</identifier><identifier>DOI: 10.1016/j.ccr.2011.09.005</identifier><identifier>PMID: 22014571</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Apoptosis - physiology ; Caspase 2 - metabolism ; Caspase 2 - physiology ; Cell Line, Tumor ; Cysteine Endopeptidases - metabolism ; Cysteine Endopeptidases - physiology ; Endoplasmic Reticulum - physiology ; Endoplasmic Reticulum Stress ; Endoribonucleases - antagonists &amp; inhibitors ; Female ; Genomics - methods ; Glioblastoma - drug therapy ; Glioblastoma - pathology ; Glioblastoma - virology ; Humans ; Mice ; Mice, Nude ; Oncolytic Virotherapy - methods ; Oncolytic Viruses - immunology ; Oncolytic Viruses - metabolism ; Oncolytic Viruses - physiology ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - virology ; Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors ; Rhabdoviridae - physiology ; Rhabdovirus ; RNA Interference</subject><ispartof>Cancer cell, 2011-10, Vol.20 (4), p.443-456</ispartof><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-aabb142854804cdf02f83fa38aa5bb3540b7f20194011171e798df4f9c611c423</citedby><cites>FETCH-LOGICAL-c493t-aabb142854804cdf02f83fa38aa5bb3540b7f20194011171e798df4f9c611c423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1535610811003539$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22014571$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahoney, Douglas J.</creatorcontrib><creatorcontrib>Lefebvre, Charles</creatorcontrib><creatorcontrib>Allan, Kristina</creatorcontrib><creatorcontrib>Brun, Jan</creatorcontrib><creatorcontrib>Sanaei, Cina A.</creatorcontrib><creatorcontrib>Baird, Stephen</creatorcontrib><creatorcontrib>Pearce, Nelson</creatorcontrib><creatorcontrib>Grönberg, Susanna</creatorcontrib><creatorcontrib>Wilson, Brian</creatorcontrib><creatorcontrib>Prakesh, Mikael</creatorcontrib><creatorcontrib>Aman, Ahmed</creatorcontrib><creatorcontrib>Isaac, Methvin</creatorcontrib><creatorcontrib>Mamai, Ahmed</creatorcontrib><creatorcontrib>Uehling, David</creatorcontrib><creatorcontrib>Al-Awar, Rima</creatorcontrib><creatorcontrib>Falls, Theresa</creatorcontrib><creatorcontrib>Alain, Tommy</creatorcontrib><creatorcontrib>Stojdl, David F.</creatorcontrib><title>Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death</title><title>Cancer cell</title><addtitle>Cancer Cell</addtitle><description>To identify therapeutic opportunities for oncolytic viral therapy, we conducted genome-wide RNAi screens to search for host factors that modulate rhabdoviral oncolysis. Our screens uncovered the endoplasmic reticulum (ER) stress response pathways as important modulators of rhabdovirus-mediated cytotoxicity. Further investigation revealed an unconventional mechanism whereby ER stress response inhibition preconditioned cancer cells, which sensitized them to caspase-2-dependent apoptosis induced by a subsequent rhabdovirus infection. Importantly, this mechanism was tumor cell specific, selectively increasing potency of the oncolytic virus by up to 10,000-fold. In vivo studies using a small molecule inhibitor of IRE1α showed dramatically improved oncolytic efficacy in resistant tumor models. Our study demonstrates proof of concept for using functional genomics to improve biotherapeutic agents for cancer. ► RNAi screen finds UPR/ERAD blockade sensitizes cancer cells to oncolytic therapy ► Cellular response to ER stress, not acute stress, predisposes cancer cells to death ► PIDD-independent caspase-2 mechanism is triggered by virus infection ► Chemical inhibition of IRE1α improves oncolytic virus therapy in vivo</description><subject>Animals</subject><subject>Apoptosis - physiology</subject><subject>Caspase 2 - metabolism</subject><subject>Caspase 2 - physiology</subject><subject>Cell Line, Tumor</subject><subject>Cysteine Endopeptidases - metabolism</subject><subject>Cysteine Endopeptidases - physiology</subject><subject>Endoplasmic Reticulum - physiology</subject><subject>Endoplasmic Reticulum Stress</subject><subject>Endoribonucleases - antagonists &amp; inhibitors</subject><subject>Female</subject><subject>Genomics - methods</subject><subject>Glioblastoma - drug therapy</subject><subject>Glioblastoma - pathology</subject><subject>Glioblastoma - virology</subject><subject>Humans</subject><subject>Mice</subject><subject>Mice, Nude</subject><subject>Oncolytic Virotherapy - methods</subject><subject>Oncolytic Viruses - immunology</subject><subject>Oncolytic Viruses - metabolism</subject><subject>Oncolytic Viruses - physiology</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - virology</subject><subject>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</subject><subject>Rhabdoviridae - physiology</subject><subject>Rhabdovirus</subject><subject>RNA Interference</subject><issn>1535-6108</issn><issn>1878-3686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUcFu1DAUtBCIlsIHcEG-cUp4TpzEFie0LVCpUqW2cLUc53nxapMstlOp_8BH86JdOMLJ1nhm3vMMY28FlAJE-2FXOhfLCoQoQZcAzTN2LlSnirpV7XO6N3VTtALUGXuV0g5IIzr9kp1VpJFNJ87Zr-8hLql4WMY58uspY7QuzyPyexcRJ36Hj2j3iV_d8fscMSVC0mGeEvKNXZ8Pcd5GO65wSNlOecUdxsQ9Od5Obt4_5eD4aU4M2y1GHIiVDjZhUfEN7vf8Em3-8Zq98DQM35zOC_bt89XD5mtxc_vlevPppnBS17mwtu-FrFQjFUg3eKi8qr2tlbVN39eNhL7z9EMtKRnRCey0Grz02rVCOFnVF-z90ZeW_7lgymYMydEadsJ5SUZX0GkNWvyfCdDW0HYNMcWR6eKcUkRvDjGMNj4ZAWZty-wMtWXWtgxoQ22R5t3JfelHHP4q_tRDhI9HAlIajwGjSS4gxTuEiC6bYQ7_sP8Nm1ilgg</recordid><startdate>20111018</startdate><enddate>20111018</enddate><creator>Mahoney, Douglas J.</creator><creator>Lefebvre, Charles</creator><creator>Allan, Kristina</creator><creator>Brun, Jan</creator><creator>Sanaei, Cina A.</creator><creator>Baird, Stephen</creator><creator>Pearce, Nelson</creator><creator>Grönberg, Susanna</creator><creator>Wilson, Brian</creator><creator>Prakesh, Mikael</creator><creator>Aman, Ahmed</creator><creator>Isaac, Methvin</creator><creator>Mamai, Ahmed</creator><creator>Uehling, David</creator><creator>Al-Awar, Rima</creator><creator>Falls, Theresa</creator><creator>Alain, Tommy</creator><creator>Stojdl, David F.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20111018</creationdate><title>Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death</title><author>Mahoney, Douglas J. ; Lefebvre, Charles ; Allan, Kristina ; Brun, Jan ; Sanaei, Cina A. ; Baird, Stephen ; Pearce, Nelson ; Grönberg, Susanna ; Wilson, Brian ; Prakesh, Mikael ; Aman, Ahmed ; Isaac, Methvin ; Mamai, Ahmed ; Uehling, David ; Al-Awar, Rima ; Falls, Theresa ; Alain, Tommy ; Stojdl, David F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-aabb142854804cdf02f83fa38aa5bb3540b7f20194011171e798df4f9c611c423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Apoptosis - physiology</topic><topic>Caspase 2 - metabolism</topic><topic>Caspase 2 - physiology</topic><topic>Cell Line, Tumor</topic><topic>Cysteine Endopeptidases - metabolism</topic><topic>Cysteine Endopeptidases - physiology</topic><topic>Endoplasmic Reticulum - physiology</topic><topic>Endoplasmic Reticulum Stress</topic><topic>Endoribonucleases - antagonists &amp; inhibitors</topic><topic>Female</topic><topic>Genomics - methods</topic><topic>Glioblastoma - drug therapy</topic><topic>Glioblastoma - pathology</topic><topic>Glioblastoma - virology</topic><topic>Humans</topic><topic>Mice</topic><topic>Mice, Nude</topic><topic>Oncolytic Virotherapy - methods</topic><topic>Oncolytic Viruses - immunology</topic><topic>Oncolytic Viruses - metabolism</topic><topic>Oncolytic Viruses - physiology</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - virology</topic><topic>Protein-Serine-Threonine Kinases - antagonists &amp; inhibitors</topic><topic>Rhabdoviridae - physiology</topic><topic>Rhabdovirus</topic><topic>RNA Interference</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahoney, Douglas J.</creatorcontrib><creatorcontrib>Lefebvre, Charles</creatorcontrib><creatorcontrib>Allan, Kristina</creatorcontrib><creatorcontrib>Brun, Jan</creatorcontrib><creatorcontrib>Sanaei, Cina A.</creatorcontrib><creatorcontrib>Baird, Stephen</creatorcontrib><creatorcontrib>Pearce, Nelson</creatorcontrib><creatorcontrib>Grönberg, Susanna</creatorcontrib><creatorcontrib>Wilson, Brian</creatorcontrib><creatorcontrib>Prakesh, Mikael</creatorcontrib><creatorcontrib>Aman, Ahmed</creatorcontrib><creatorcontrib>Isaac, Methvin</creatorcontrib><creatorcontrib>Mamai, Ahmed</creatorcontrib><creatorcontrib>Uehling, David</creatorcontrib><creatorcontrib>Al-Awar, Rima</creatorcontrib><creatorcontrib>Falls, Theresa</creatorcontrib><creatorcontrib>Alain, Tommy</creatorcontrib><creatorcontrib>Stojdl, David F.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cancer cell</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahoney, Douglas J.</au><au>Lefebvre, Charles</au><au>Allan, Kristina</au><au>Brun, Jan</au><au>Sanaei, Cina A.</au><au>Baird, Stephen</au><au>Pearce, Nelson</au><au>Grönberg, Susanna</au><au>Wilson, Brian</au><au>Prakesh, Mikael</au><au>Aman, Ahmed</au><au>Isaac, Methvin</au><au>Mamai, Ahmed</au><au>Uehling, David</au><au>Al-Awar, Rima</au><au>Falls, Theresa</au><au>Alain, Tommy</au><au>Stojdl, David F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death</atitle><jtitle>Cancer cell</jtitle><addtitle>Cancer Cell</addtitle><date>2011-10-18</date><risdate>2011</risdate><volume>20</volume><issue>4</issue><spage>443</spage><epage>456</epage><pages>443-456</pages><issn>1535-6108</issn><eissn>1878-3686</eissn><abstract>To identify therapeutic opportunities for oncolytic viral therapy, we conducted genome-wide RNAi screens to search for host factors that modulate rhabdoviral oncolysis. Our screens uncovered the endoplasmic reticulum (ER) stress response pathways as important modulators of rhabdovirus-mediated cytotoxicity. Further investigation revealed an unconventional mechanism whereby ER stress response inhibition preconditioned cancer cells, which sensitized them to caspase-2-dependent apoptosis induced by a subsequent rhabdovirus infection. Importantly, this mechanism was tumor cell specific, selectively increasing potency of the oncolytic virus by up to 10,000-fold. In vivo studies using a small molecule inhibitor of IRE1α showed dramatically improved oncolytic efficacy in resistant tumor models. Our study demonstrates proof of concept for using functional genomics to improve biotherapeutic agents for cancer. ► RNAi screen finds UPR/ERAD blockade sensitizes cancer cells to oncolytic therapy ► Cellular response to ER stress, not acute stress, predisposes cancer cells to death ► PIDD-independent caspase-2 mechanism is triggered by virus infection ► Chemical inhibition of IRE1α improves oncolytic virus therapy in vivo</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>22014571</pmid><doi>10.1016/j.ccr.2011.09.005</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1535-6108
ispartof Cancer cell, 2011-10, Vol.20 (4), p.443-456
issn 1535-6108
1878-3686
language eng
recordid cdi_proquest_miscellaneous_920799091
source MEDLINE; Elsevier ScienceDirect Journals Complete; Cell Press Free Archives; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Animals
Apoptosis - physiology
Caspase 2 - metabolism
Caspase 2 - physiology
Cell Line, Tumor
Cysteine Endopeptidases - metabolism
Cysteine Endopeptidases - physiology
Endoplasmic Reticulum - physiology
Endoplasmic Reticulum Stress
Endoribonucleases - antagonists & inhibitors
Female
Genomics - methods
Glioblastoma - drug therapy
Glioblastoma - pathology
Glioblastoma - virology
Humans
Mice
Mice, Nude
Oncolytic Virotherapy - methods
Oncolytic Viruses - immunology
Oncolytic Viruses - metabolism
Oncolytic Viruses - physiology
Ovarian Neoplasms - drug therapy
Ovarian Neoplasms - pathology
Ovarian Neoplasms - virology
Protein-Serine-Threonine Kinases - antagonists & inhibitors
Rhabdoviridae - physiology
Rhabdovirus
RNA Interference
title Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A47%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Virus-Tumor%20Interactome%20Screen%20Reveals%20ER%20Stress%20Response%20Can%20Reprogram%20Resistant%20Cancers%20for%20Oncolytic%20Virus-Triggered%20Caspase-2%20Cell%20Death&rft.jtitle=Cancer%20cell&rft.au=Mahoney,%20Douglas%C2%A0J.&rft.date=2011-10-18&rft.volume=20&rft.issue=4&rft.spage=443&rft.epage=456&rft.pages=443-456&rft.issn=1535-6108&rft.eissn=1878-3686&rft_id=info:doi/10.1016/j.ccr.2011.09.005&rft_dat=%3Cproquest_cross%3E920799091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=900630675&rft_id=info:pmid/22014571&rft_els_id=S1535610811003539&rfr_iscdi=true